In the setting of NAFLD, lipid metabolism dysregulation, the release of specific metabolites, including linoleic acids, and increased ROS induce a selective loss of CD4+ T cells [195]. Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.